3 Catalysts To Watch Over The Next Couple Months For This Pharma Co.

By: via Benzinga
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares are down 33 percent year-to-date after having peaked at $9.32 on March ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.